Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : anika research(anik) -- Ignore unavailable to you. Want to Upgrade?

To: Jon Nunley who wrote (101)	2/24/1998 10:51:00 AM
From: chirodoc	Respond to of 328

<<<<Anika Therapeutics Reports 1997 Year-End Results .....saw stock popped yesterday, wondered why, saw the same thing but you beat me to it. thanks! ......IF we get approval and are more profitable this baby could easily see $12-$15. however, with these bios i have no hopes and try to stay near the maalox. .......however, the low toxicity profile and the fact that it is being used in europe as well as the acceptance of competing products (assuming they do their app correctly) gives us good risk reward imho.